UPDATE: Oppenheimer Starts MindMed (MNMD) at Outperform; 'A Psychedelic Leader Driven By Extensive Data'
Tweet Send to a Friend
(Updated - August 25, 2022 5:26 PM EDT)
Oppenheimer analyst Francois Brisebois initiates coverage on MindMed (NASDAQ: MNMD) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Francois Brisebois initiates coverage on MindMed (NASDAQ: MNMD) with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
